The 26-item Home Dialysis Care Experience instrument assesses patient-reported experiences with peritoneal dialysis and home hemodialysis.
Increases in FGF23 may lead to cardiac remodeling in these patients, investigators suggest.
Investigators also confirmed racial disparities in COVID-19 hospitalizations and overall deaths early in the pandemic among patients with ESKD.
Nearly 74% of hemodialysis patients experienced pre-dialysis hyperkalemia within 1 year of enrollment in the Dialysis Outcomes and Practice Patterns Study, according to investigators.
Roxadustat reduced the need for rescue therapy among patients with any stage of chronic kidney disease.
The overriding concern of vaccine-hesitant patients related to side effects, followed by doubts about the efficacy of a vaccine, and discomfort with vaccines in general, according to investigators.
New study is the first to characterize pegloticase use in the dialysis population.
Age was an important factor in the humoral response, regardless of chronic medical conditions.
More infections came as hospitals experienced high numbers of COVID-19 admissions
Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.